These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 17252017
1. Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients. O'Neill KL, Zhang F, Li H, Fuja DG, Murray BK. Leukemia; 2007 Mar; 21(3):560-3. PubMed ID: 17252017 [No Abstract] [Full Text] [Related]
2. Clinical and biological significance of serum tumor markers in adult T-cell leukemia. Sadamori N. Leuk Lymphoma; 1996 Aug; 22(5-6):415-9. PubMed ID: 8882954 [Abstract] [Full Text] [Related]
3. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO). Iwata H, Kami M, Kishi Y, Oki Y, Tanaka Y, Takeuchi K, Yamazaki I, Suzuki R, Morinaga S, Mutou Y. Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040 [No Abstract] [Full Text] [Related]
4. Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia. Sadamori N, Ichiba M, Mine M, Hakariya S, Hayashibara T, Itoyama T, Nakamura H, Tomonaga M, Hayashi K. Br J Haematol; 1995 May; 90(1):100-5. PubMed ID: 7786770 [Abstract] [Full Text] [Related]
5. Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia. Blink M, Buitenkamp TD, van den Heuvel-Eibrink MM, Danen-van Oorschot AA, de Haas V, Reinhardt D, Klusmann JH, Zimmermann M, Devidas M, Carroll AJ, Basso G, Pession A, Hasle H, Pieters R, Rabin KR, Izraeli S, Zwaan CM. Leukemia; 2011 Aug; 25(8):1365-8. PubMed ID: 21537335 [No Abstract] [Full Text] [Related]
6. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia. Ludescher C, Eisterer W, Hilbe W, Gotwald M, Hofmann J, Zabernigg A, Cianfriglia M, Thaler J. Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774 [Abstract] [Full Text] [Related]
7. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker. Jagarlamudi KK, Shaw M. Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979 [Abstract] [Full Text] [Related]
8. Cytokines and DIC in acute leukaemia. Guarini A, Gugliotta L, Bianchi A, De Groote D, Foa R. Eur J Haematol; 1990 Aug; 45(2):121-2. PubMed ID: 2209819 [No Abstract] [Full Text] [Related]
9. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts. Muroi K, Amemiya Y, Miura Y, Nakamura M, Suda T. Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130 [No Abstract] [Full Text] [Related]
15. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome. Vinante F, Rigo A, Tecchio C, Morosato L, Nadali G, Ricetti MM, Krampera M, Zanolin E, Locatelli F, Gallati H, Chilosi M, Pizzolo G. Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654 [Abstract] [Full Text] [Related]
18. SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis. Mu Q, Guo L, Hu Y, Sheng L, Zhang Y, Wu N, Chen Y, Shi C, Shi S, Wu Y, Ouyang G. Leuk Lymphoma; 2017 Sep; 58(9):1-3. PubMed ID: 28278724 [No Abstract] [Full Text] [Related]